G
Gaurav Goyal
Researcher at University of Alabama at Birmingham
Publications - 122
Citations - 1530
Gaurav Goyal is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 16, co-authored 81 publications receiving 731 citations. Previous affiliations of Gaurav Goyal include Mayo Clinic & Creighton University Medical Center.
Papers
More filters
Journal ArticleDOI
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era
Gaurav Goyal,Mark L. Heaney,Matthew Collin,Matthew Collin,Fleur Cohen-Aubart,Augusto Vaglio,Benjamin H. Durham,Oshrat Hershkovitz-Rokah,Oshrat Hershkovitz-Rokah,Michael Girschikofsky,Eric D. Jacobsen,Kazuhiro Toyama,Aaron M. Goodman,Paul C. Hendrie,Xin Xin Cao,Juvianee Estrada-Veras,Ofer Shpilberg,Ofer Shpilberg,Andre Abdo,Mineo Kurokawa,Lorenzo Dagna,Kenneth L. McClain,Roei D Mazor,Jennifer Picarsic,Filip Janku,Ronald S. Go,Julien Haroche,Eli L. Diamond +27 more
TL;DR: These guidelines for the clinical, laboratory, histologic, and radiographic evaluation of ECD patients along with treatment recommendations based on clinical experience and review of literature in the molecular era are presented.
Journal ArticleDOI
The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease
Gaurav Goyal,Jason R. Young,Matthew J. Koster,W. Oliver Tobin,Robert Vassallo,Jay H. Ryu,Caroline J. Davidge-Pitts,Maria D. Hurtado,Aishwarya Ravindran,Julio C. Sartori Valinotti,N. Nora Bennani,Mithun Vinod Shah,Karen L. Rech,Ronald S. Go +13 more
TL;DR: This consensus statement represents a joint document from a multidisciplinary group of physicians at Mayo Clinic who specialize in the management of adult histiocytic neoplasms and consists of evidence- and consensus-based recommendations on when to suspect these neoplasm and what tests to order for the diagnosis and initial evaluation.
Journal ArticleDOI
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease
Gaurav Goyal,Aishwarya Ravindran,Jason R. Young,Mithun Vinod Shah,N. Nora Bennani,Mrinal M. Patnaik,Grzegorz S. Nowakowski,Gita Thanarajasingam,Thomas M. Habermann,Robert Vassallo,Taimur Sher,Sameer A. Parikh,Karen L. Rech,Ronald S. Go +13 more
TL;DR: It is demonstrated that Rosai-Dorfman disease has diverse clinical manifestations and outcomes, while this disease has been historically considered a benign entity, a subset of patients endures an aggressive course necessitating the use of systemic therapies.
Journal ArticleDOI
Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes.
TL;DR: HS is a rare hematopoietic neoplasm derived from non-Langerhans histiocytic cells of the monocyte/macrophage system that is diagnosed using immunohistochemistry markers, such as CD68, lysozyme, CD4, and CD163, on the tissue biopsies.
Journal ArticleDOI
Contemporary Management of Localized Resectable Pancreatic Cancer.
TL;DR: Accumulating evidence suggests that the neoadjuvant approach may improve R0 resection rate in localized resectables and borderline resectable diseases, and potentially downstage locally advanced disease to achieve surgical resection, though the impact on survival is to be determined.